Philippines Diabetes Care Devices Market Size- By Monitoring Devices, By Management Devices- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Philippines Diabetes Care Devices Market Introduction and Overview

According to SPER market research, 'Philippines Diabetes Care Devices Market Size - By Monitoring Devices, By Management Devices - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Philippines Diabetes Care Devices Market is predicted to reach USD 127.93 million by 2033 with a CAGR of 5.91%.

Diabetes care equipment measures blood sugar levels. Insulin is produced by the body to keep blood sugar levels stable. Patients with diabetes are given these medical gadgets to assist them accurately monitor their blood glucose levels and manage their long-term condition. Diabetes care devices are typically used by people with diabetes to track their blood glucose levels. People with diabetes use a continuous glucose monitor (CGM) to track and keep an eye on their blood glucose levels all day long.

The COVID-19 epidemic has had a major effect on the Philippines Diabetes Care Devices Market. Even if the prevalence of diabetes in the nation is still rising, managing the condition is getting harder due to the pandemic's disruption of healthcare services and access to medical facilities. Regular tests, consultations, and check-ups for diabetes patients have been canceled or postponed due to travel restrictions, lockdowns, and quarantine orders.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Monitoring Devices, By Management Devices

Regions covered Eastern Region, Western Region, Northern Region, Southern Region

Companies Covered Abbott, Becton and Dickenson, Dexcom, Eli Lilly, Insulet, Lifescan, Medtronic, Novo Nordisk, Roche, Sanofi, Tandem

Philippines Diabetes Care Devices Market Segmentation

By Monitoring Devices: Based on the Monitoring Devices, Philippines Diabetes Care Devices Market is segmented as; Self-monitoring Blood Glucose Devices, Continuous Blood Glucose Monitoring.

By Management Devices: Based on the Management Devices, Philippines Diabetes Care Devices Market is segmented as; Insulin Pump, Insulin Syringers, Insulin Cartridges, Disposable Pens, Others.

By Region: This research also includes data for Eastern Region, Western Region, Northern Region, Southern Region.

Product Code: MEDE2407

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Philippines Diabetes Care Devices Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Philippines Diabetes Care Devices Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Philippines Diabetes Care Devices Market

7. Philippines Diabetes Care Devices Market, By Monitoring Devices (USD Million)

7.1. Philippines Diabetes Care Devices Market Value Share and Forecast, By Monitoring Devices, 2023-2033
7.2. Self-monitoring Blood Glucose Devices
- 7.2.1. Glucometer Devices
- 7.2.2. Test Strips
- 7.2.3. Lancets
7.3. Continuous Blood Glucose Monitoring
- 7.3.1. Sensors
- 7.3.2. Durables

8. Philippines Diabetes Care Devices Market, By Management Devices (USD Million)

8.1. Philippines Diabetes Care Devices Market Value Share and Forecast, By Management Devices, 2023-2033
8.2. Insulin Pump
- 8.2.1. Insulin Pump Devices
- 8.2.2. Insulin Pump Reservoir
- 8.2.3. Infusion Set
8.3. Insulin Syringers
8.4. Insulin Cartridges
8.5. Disposable Pens
8.6. Others

9. Philippines Diabetes Care Devices Market Forecast, 2020-2033 (USD Million)

9.1. Philippines Diabetes Care Devices Market Size and Market Share

10. Philippines Diabetes Care Devices Market, By Monitoring Devices, 2020-2033 (USD Million)

10.1. Philippines Diabetes Care Devices Market Size and Market Share By Monitoring Devices (2020-2026)
10.2. Philippines Diabetes Care Devices Market Size and Market Share By Monitoring Devices (2027-2033)

11. Philippines Diabetes Care Devices Market, By Management Devices, 2020-2033 (USD Million)

11.1. Philippines Diabetes Care Devices Market Size and Market Share By Management Devices (2020-2026)
11.2. Philippines Diabetes Care Devices Market Size and Market Share By Management Devices (2027-2033)

12. Philippines Diabetes Care Devices Market, By Region, 2020-2033 (USD Million)

12.1. Philippines Diabetes Care Devices Market Size and Market Share By Region (2020-2026)
12.2. Philippines Diabetes Care Devices Market Size and Market Share By Region (2027-2033)
12.3. Eastern Region
12.4. Western Region
12.5. Northern Region
12.6. Southern Region

13. Company Profile

13.1. Abbott
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
13.2. Becton and Dickenson
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
13.3. Dexcom
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
13.4. Eli Lilly
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
13.5. Insulet
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
13.6. Lifescan
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
13.7. Medtronic
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
13.8. Novo Nordisk
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
13.9. Roche
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
13.10. Sanofi
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3. Product summary
- 13.10.4. Recent developments
13.11. Tandem
- 13.11.1. Company details
- 13.11.2. Financial outlook
- 13.11.3. Product summary
- 13.11.4. Recent developments
13.12. Others